MedTrace Logo

Tuberculosis as a Risk Factor for a Worse Outcome Post-Sars-CoV-2 Infection

NCT05643781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 157

Last updated 2023-01-11

No results posted yet for this study

Summary

This study has two main objectives. First, the clinical characteristics and outcomes of hospitalized patients with symptomatic Covid-19 disease will be compared between persons with a history of past or current TB infection or disease and those, who have had no TB history. The possible impact of an HIV-coinfection will be also addressed in the planned investigations and analysis. Second, the long-term consequences and clinical outcomes of Covid-19 up to 12 months post-infection will be analysed in both groups (with and without TB history) with the main focus on cardio-pulmonary outcomes.

Conditions

Sponsors & Collaborators

  • Chris Hani Baragwanath Academic Hospital

    collaborator OTHER

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • The Aurum Institute NPC

    lead OTHER

Principal Investigators

  • Andrea Rachow, PhD, med · Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU)

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-23
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05643781 on ClinicalTrials.gov